Park Square has placed Derek Hicks as Chief Executive Officer at Rezo Therapeutics.
Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, today announced that Derek Hicks was appointed CEO.
